Journals / Bakırköy Tıp Dergisi / 2015 / Cilt: 11 - Sayı: 3

The role of adiponectin in the immunopathogenesis of multiple sclerosis

The Role of Adiponectin in The Immunopathogenesis of Multiple Sclerosis

Pages
95–98
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings give rise to the thought that adiponectin which has immunological functions may play a role in immunopathogenesis of MS and its signal transduction pathways and gene expression regulation may be a new target in treatment with the help of developing nano technology

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Adiponectin from adipocytokines plays role in neuro-inflammation, neuroimmunoendocrine system modulation and immune system regulation and has anti-inflammatory and protective effects.
📊
Key Findings & Data:Student’s t-test was used for statistical analysis. p<0.05 was accepted as significant.
💡
Conclusion & Impact:Conclusion: Our findings give rise to the thought that adiponectin which has immunological functions may play a role in immunopathogenesis of MS and its signal transduction pathways and gene expression regulation may be a new target in treatment with the help of developing nano technology
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Adiponectin from adipocytokines plays role in neuro-inflammation, neuroimmunoendocrine system modulation and immune system regulation and has anti-inflammatory and protective effects. It functions by interacting pro-inflammatory cytokines, vasoactive peptides and complement proteins through peripheral and central mechanisms. The studies related to immunopathogenesis of Multiple Sclerosis (MS) progressing with neuroinflammation and neurodegeneration are focused on immune cells, cytokine, chemokines, membrane proteins, adhesion molecules and gene polymorphisms. We planned to determine the role of adipocyte related adiponectin in MS immunopathogenesis since the immunological functions of adipose tissue has drawn attention in the last years. Material and Methods: Adiponectin levels were comparatively measured with serum samples of MS patients taken during and after attacks and control samples by using ELISA method. Student’s t-test was used for statistical analysis. p<0.05 was accepted as significant. Results: It was observed that adiponectin levels were extremely decreased in MS patients during attack compared to control group and the period after attack. Conclusion: Our findings give rise to the thought that adiponectin which has immunological functions may play a role in immunopathogenesis of MS and its signal transduction pathways and gene expression regulation may be a new target in treatment with the help of developing nano technology

Özet

Amaç: Adipositokinlerden olan adiponektin nöroinflamasyon, nöroimmunoendokrin sistem modülasyonu ve immun sistem regülasyonunda rol oynar. Antienflamatuar ve protektif etkileri vardır. Fonksiyonlarını, proinflamatuar sitokinler, vazoaktif peptidler ve kompleman proteinleri ile etkileşerek periferik ve santral mekanizmalar aracılığı ile gösterir. Nöroinflamasyon ve nörodejenerasyon ile ilerleyen multipl sklerozun immunopatogenezi ile ilişkili çalışmalar immun hücreler, sitokinler, kemokinler, membran proteinleri, adhezyon molekülleri ve gen polimorfizmi üzerinde odaklanmaktadır. Son yıllarda adipoz dokunun immünolojik fonksiyonlar üzerindeki etkisine dikkat çekilmekte olduğundan, MS immunopatogenezinde adiposit ilişkili adiponektinin rolünü belirlemeyi planladık. Gereç ve Yöntem: Atak ve atak sonrası dönemlerde MS hastalarından alınan serum örnekleri kontrollerin serum örnekleri ile ELISA yöntemi ile, karşılaştırmalı olarak ölçüldü. İstatistiksel analiz için Student’s t test kullanıldı. p<0.05 anlamlı kabul edildi. Bulgular: Adiponektin düzeylerinin MS hastalarında, atak sırasında, kontrollere göre ve ataktan sonraki döneme göre anlamlı şekilde daha düşük olduğu gözlendi. Sonuç: Bulgularımız, immünolojik fonksiyonları olan adiponektinin MS immunopatogenezinde rolü olacağı düşüncesini ve sinyal transdüksiyon yolakları ve gen ekspresyon regülasyonunun, gelişen nanoteknolojisi yardımı ile yeni bir tedavi hedefi olabileceği görüşünü desteklemektedir.

🔖

Cite This Article

ARLI, B., İRKEÇ, C. (2015). The role of adiponectin in the immunopathogenesis of multiple sclerosis. Bakırköy Tıp Dergisi, Cilt: 11 - Sayı: 3, 95–98. https://ajindex.com/articles/128884

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ouchin, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007; 380: 24-30
  2. Costa JV, Duarte JS. Adipose tissue and adipokines. Act Med Port 2006; 19: 251-256
  3. Guzik TS, Mangalat D, Korbut R. Adipocytokines-novel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57: 505-528
  4. Engeli S, Jordan J. The endocannabinoid system: body weight and metabolic regulation. Clin Cornerstone 2006; 8: 24-35
  5. Ahima RS, Qr Y, Singhal NS, Jackson MB, Scherer PE. Brain adipocytokine action and metabolic regulation. Diabetes 2006; 55: s145-154
  6. Delaigle AM, Jonas JL, Bauche IB, Cornu O, Brichard SM. Induction of adinopectin in skletal mucle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004; 145: 5589-5597
  7. Kawanami D, Maemurakk, Takedo N, Harade T, Nojiri T, Imai Y, Manabe I. Direct reciprocal effects of resistin and adiponectin on vascular andothelial cells: a new insight into adipocytokine- endothelial cell interactions. Biochem Biophys Res Commun 2004; 6: 415-419
  8. McDonald WI, Compston A, Edan G, Goodkin D, Polman CH, Reingold SC. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127
  9. Drulovic S, Mostarica-Stojkovic M, Levic Z. Interleukin-12 and tumor necrosis factor alpha levels in cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci 1997; 147: 145-150
  10. Niino M, Ogata A, Kikuchi S, Tashiro H, Nishihira J. Macrophage migration inhibitory factor inde cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet’s disease. J Neurol Sci 2000; 179: 127-131
  11. Franciotta D, zardini E, Bergamaschi R, Andreoni L, Cosi V. Interferon-gamma and interleukin-4 producing T cells in peripheral blood of multiple sclerosis patients. Eur Cytokine Netw 2000; 11: 677-681
  12. Mahad DS, Howell SSL, Woodroofe MN. Expression of chemokines in CSF and correlation with clinical disease activity in patients with multiple sclerosis. J.Neurol Neurosurg Psychiatry 2002; 73: 320-323
  13. Ransohoff RM. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 1999; 98: 57-68
  14. Scarpini E, Galimberti D, Baron P, Clerici R. IP-10 and MCP-1 in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. J Neurol Sci 2002; 195: 41-46
  15. Direskeneli GS, Yentür SP, Dem